ArticleContrast media & molecular imaging2018
Comparison of
Article in Contrast media & molecular imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 13 citations in OpenAlex.
- Comparison ofScientific reports · 2025Article
- Comparison ofScientific reports · 2025Article
- Enhanced detection of skull-base bone invasion in nasopharyngeal carcinoma: the supplementary diagnostic value ofQuantitative imaging in medicine and surgery · 2024Article
- Intravoxel incoherent motion diffusion-weighted imaging (IVIM-DWI) combined with conventional MRI for the detection of skull-base invasion in nasopharyngeal carcinoma: comparison withQuantitative imaging in medicine and surgery · 2024Article
- The role of PET/CT in radiotherapy for nasopharyngeal carcinoma.Frontiers in oncology · 2022Review
- Comparison of Bone Metastases betweenContrast media & molecular imaging · 2022Article
- The value ofFrontiers in bioengineering and biotechnology · 2022Article
- Prospective comparison ofFrontiers in oncology · 2022Article
- Clinical utility of [European journal of nuclear medicine and molecular imaging · 2021Article
- Emerging radiotherapy technologies and trends in nasopharyngeal cancer.Cancer communications (London, England) · 2020Review
- Liquid Biopsy in Oligometastatic Prostate Cancer-A Biologist's Point of View.Frontiers in oncology · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Our study aimed at comparing the diagnostic value of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.